Hepatitis C
The MD Magazine Hepatitis C condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Study Finds Large Percentage of Hepatitis C Patients Initially Denied Treatment
Researchers report that nearly one in four patients with hepatitis C are denied initial approval for treatment.
The debate over whether state Medicaid programs are violating federal law by restricting access to pricey new hepatitis-C drugs is getting hotter. The While House is under new pressure to step in.
Experts from the Public Health Service and President Obama’s Advisory Council on HIV/AIDS have asked the administration in a letter to widen access to new, high-cost medications that successfully treat hepatitis C.
Researchers have struggled to grow the hepatitis C virus (HCV) in a clinical lab setting since its discovery in 1989. However, a recent discovery about HCV genetics may have just changed that.
A new strategy may be able to effectively prevent transmission of the human immunodeficiency virus (HIV), other sexually transmitted viruses, and additional illnesses.
It is well-known that patients with hepatitis C face a higher risk of liver complications; however, a new study discovered that the heart could also be in trouble.
Hepatitis C medication development pipeline still strong, with several additional drugs poised for approval.

Most Popular

$vacMongoViewPlus$ $vAR$